The phosphopeptide-binding specificity of Src family SH2 domains. 1994

G Payne, and L A Stolz, and D Pei, and H Band, and S E Shoelson, and C T Walsh
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.

BACKGROUND Src homology 2 (SH2) domains mediate protein/protein interactions by binding phosphotyrosyl proteins with high specificity. The protein Lck, a Src-like lymphocyte-specific tyrosine kinase which is important in signals involved in T-cell development, contains one such domain. The crystal structure of a complex of the Lck SH2 domain with a high-affinity ligand, pY324, is known. This ligand has the sequence EPQpYEEIPIYL. RESULTS We designed and synthesized a series of phosphopeptides with single amino-acid changes in the four residues C-terminal to the phosphotyrosine (pTyr) in pY324. Surprisingly, the Glu one residue C-terminal to the phosphotyrosine (at position pY + 1) is sensitive to substitution, whereas the Ile at position pY + 3 is much less sensitive, accommodating a Glu with only modest loss of binding affinity. Replacement of the Glu and Pro on either side of the Ile had little effect, as predicted. Truncated phosphopeptides that end at position pY + 5 and have only an acetyl group N-terminal to the pTyr bound with only slightly lower affinity than pY324. In addition, naturally occurring phosphopeptide sequences that span a 1,000-fold range in binding affinity for the Lck SH2 domain have been identified. CONCLUSIONS The Lck SH2 domain is highly selective for phosphotyrosyl-peptide binding; its specificity is dictated by the first and third residues C-terminal to the pTyr. The unexpected effects of some amino-acid substitutions indicate that the interactions seen between SH2 domains and ligand in the crystal structure may not be identical to those that occur in solution.

UI MeSH Term Description Entries
D010748 Phosphopeptides PEPTIDES that incorporate a phosphate group via PHOSPHORYLATION. Phosphopeptide
D011993 Recombinant Fusion Proteins Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes. Fusion Proteins, Recombinant,Recombinant Chimeric Protein,Recombinant Fusion Protein,Recombinant Hybrid Protein,Chimeric Proteins, Recombinant,Hybrid Proteins, Recombinant,Recombinant Chimeric Proteins,Recombinant Hybrid Proteins,Chimeric Protein, Recombinant,Fusion Protein, Recombinant,Hybrid Protein, Recombinant,Protein, Recombinant Chimeric,Protein, Recombinant Fusion,Protein, Recombinant Hybrid,Proteins, Recombinant Chimeric,Proteins, Recombinant Fusion,Proteins, Recombinant Hybrid
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016391 Genes, src Retrovirus-associated DNA sequences (src) originally isolated from the Rous sarcoma virus (RSV). The proto-oncogene src (c-src) codes for a protein that is a member of the tyrosine kinase family and was the first proto-oncogene identified in the human genome. The human c-src gene is located at 20q12-13 on the long arm of chromosome 20. c-src Genes,src Genes,v-src Genes,c-src Proto-Oncogenes,src Gene,src Oncogene,v-src Oncogenes,Gene, c-src,Gene, src,Gene, v-src,Genes, c-src,Genes, v-src,Oncogene, src,Oncogene, v-src,Oncogenes, src,Oncogenes, v-src,Proto-Oncogene, c-src,Proto-Oncogenes, c-src,c src Genes,c src Proto Oncogenes,c-src Gene,c-src Proto-Oncogene,src Oncogenes,v src Genes,v src Oncogenes,v-src Gene,v-src Oncogene
D018360 Crystallography, X-Ray The study of crystal structure using X-RAY DIFFRACTION techniques. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) X-Ray Crystallography,Crystallography, X Ray,Crystallography, Xray,X Ray Crystallography,Xray Crystallography,Crystallographies, X Ray,X Ray Crystallographies
D018909 src Homology Domains Regions of AMINO ACID SEQUENCE similarity in the SRC-FAMILY TYROSINE KINASES that fold into specific functional tertiary structures. The SH1 domain is a CATALYTIC DOMAIN. SH2 and SH3 domains are protein interaction domains. SH2 usually binds PHOSPHOTYROSINE-containing proteins and SH3 interacts with CYTOSKELETAL PROTEINS. SH Domains,SH1 Domain,SH2 Domain,SH3 Domain,src Homology Region 2 Domain,Homology Domain, src,Homology Domains, src,SH Domain,SH1 Domains,SH2 Domains,SH3 Domains,src Homology Domain

Related Publications

G Payne, and L A Stolz, and D Pei, and H Band, and S E Shoelson, and C T Walsh
October 2002, Bioorganic & medicinal chemistry letters,
G Payne, and L A Stolz, and D Pei, and H Band, and S E Shoelson, and C T Walsh
March 2010, Chemistry & biology,
G Payne, and L A Stolz, and D Pei, and H Band, and S E Shoelson, and C T Walsh
March 1993, Cell,
G Payne, and L A Stolz, and D Pei, and H Band, and S E Shoelson, and C T Walsh
June 1995, The Journal of biological chemistry,
G Payne, and L A Stolz, and D Pei, and H Band, and S E Shoelson, and C T Walsh
April 1993, Biochemistry,
G Payne, and L A Stolz, and D Pei, and H Band, and S E Shoelson, and C T Walsh
April 2012, Journal of chemical theory and computation,
G Payne, and L A Stolz, and D Pei, and H Band, and S E Shoelson, and C T Walsh
August 1996, Biochemistry,
G Payne, and L A Stolz, and D Pei, and H Band, and S E Shoelson, and C T Walsh
January 2023, Methods in molecular biology (Clifton, N.J.),
G Payne, and L A Stolz, and D Pei, and H Band, and S E Shoelson, and C T Walsh
January 2017, The Journal of biological chemistry,
Copied contents to your clipboard!